NSPR: InspireMD, Inc. Company Profile & Statistics

About

InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel.

Info & Links

CEO

Marvin Slosman

Headquarters

4 MENORAT HAMAOR ST.
TEL AVIV, L3 6744832, ISRAEL

Auditor

Kesselman & Kesselman

Share holders

278

Employees

InspireMD, Inc. Statistics

Valuation Measures

Market Capitalization²

92.21M

Enterprise Value

76.39M

Enterprise Value/EBITDA(ttm)

-2.57

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

11.85

Price to Book(mrq)

1.87

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

22.48%

Operating Margin(ttm)

-413.96%

Profit Margin(ttm)

-415.76%

Return on Equity(ttm)

-69.42%

Return on Invested Capital(ttm)

-69.72%

Return on Assets(ttm)

-57.68%

Income Statement

Revenue(ttm)

6.82M

Revenue Per Share(ttm)

0.26

Gross Profit(ttm)

1.54M

EBITDA(ttm)³

-29.68M

Net Income Available to Common(ttm)

-28.24M

Diluted EPS(ttm)

-0.75

Share Statistics

Beta (5Y Monthly)

1.00

52-Week Change

37.51%

S&P 500 52-Week Change

18.02%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

26.08M

Dividend Yield

0.00%

Float⁴

18.33M

% Held by Insiders

29.72%

% Held by Institutions

44.78%

Balance Sheet

Total Cash(mrq)

40.40M

Total Cash Per Share(mrq)

1.55

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.39%

Quick Ratio(mrq)

6.05%

Book Value Per Share(mrq)

1.61

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.31

Free Cash Flow(ytd)

-16.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

NSPR

InspireMD, Inc.

InspireMD, Inc. Profile